Skip to main content
. 2018 Sep 22;10(10):349. doi: 10.3390/cancers10100349

Table 1.

Alcohol and Breast Cancer: Recent Epidemiological Studies.

Number Study Design Age (yearrs) at Baseline Data Collection Unit of Measurement Outcomes Ref
2017
1 Longitudinal cohort
NIH-AARP Diet and Health Study
190,325 postmenopausal women
55–70 Self-report Avg. alcohol consumption (g/day) in 12 mo. before questionnaire completion
  • Similar associations were found between alcohol consumption (0.01–10 g/day) and ductal carcinoma in situ (HR = 1.05 [0.93–1.19]) on the one hand and invasive ductal carcinomas (HR = 1.03 [0.97–1.08]) on the other

[108]
2 Prospective cohort
Nurses’ Health Study II 93,835 US women
27–44 Semi-quantitative food questionnaire Calculated total daily alcohol consumption
  • Alcohol consumption was not associated with breast cancer risk overall for intake of ≥10 g/day vs. nondrinking (HR = 1.07 [0.94–1.22])

  • Positive association between alcohol consumption and breast cancer was found among women with a family history and folate intake < 400 μg/day (HR = 1.82 [1.06–3.12])

[109]
3 Sister Study
50,884 women
35–74 Self-report Lifetime alcohol intake
  • High lifetime alcohol intake (≥230 drinks/year) increased breast cancer risk (HR = 1.35 [1.15–1.58])

  • For binge drinking (HR = 1.29, [1.15–1.45])

[110]
2016
4 Prospective cohort
Nurse’s Health Study
105,972 women
30–55 Semi-quantitative food frequency questionnaire Cumulative average alcohol intake
  • 10 g/day (HR = 1.1 [1.05–1.15 for luminal A]) and (HR = 1.16 [1.02–1.33 for HER2 BC]), but not with luminal B (HR = 1.08, [0.99–1.16)]

  • Hormonal and non-hormonal mechanisms may play a role in this association

[111]
5 Case-control
Carolina Breast Cancer Study; 781 Afr. Am. women; 1014 White women
25–50 Alcohol intake (self-report) most proximal to diagnosis Drinks per week
  • Consuming more than 7 drinks/week was significantly associated with increased risk of ER− (OR = 2.17 [1.25–3.75]) and triple-negative (ER−/PR−/HER2–) in African American women but not in White women

[112]
2015
6 Cohort study
French E3N-EPIC
66,481 women
40–65 Self-report diet-history questionnaire Cumulative average drinks/day
  • No association was found between drinking ≥2 drinks/day (beer, wine or spirits) and increase in breast cancer risk in premenopausal period

  • ≥2 drinks/day of beer or wine was associated with increased breast cancer risk (HR = 1.85 [1.19–2.89], 1.33 [1.11–1.58]) in postmenopausal period

  • This relationship was observed primarily in ER+/PR+ breast cancer risk (HR = 1.32 [1.08–1.60])

[113]
7 Prospective
EPIC Study
334,850 women
35–70 Dietary and lifestyle questionnaires Average lifetime alcohol intake
  • 10 g/day increased breast cancer risk by 4.2%

  • For intake of 5.1–15 g/day

    ER+/PR+ (HR = 1.09 [1.00–1.18])

    ER+/PR− (HR = 1.13 [0.97–1.31)

    ER−/PR−/HER2– (HR = 1.18 [0.84–1.66])

  • Association between alcohol and breast cancer

[114]
8 Case-control
585 cases
28–90 Self-administered questionnaire Total number of alcoholic drinks per week
  • <5 drinks per week was associated with increased risk of ER+ tumors

  • In postmenopausal women: ER+ (OR = 2.32

    [1.4–3.84]); ER+/PR− (OR = 2.92 [1.29–6.63]);

    ER+/PR+ (OR = 1.97 [1.08–3.57])

[115]
9 Prospective
45,233 women
30–49 Self-report Current number of drinks/week converted to g/day
  • Alcohol intake was not statistically significantly associated with breast cancer risk, either overall or in different hormone receptor subtypes

  • Overall, breast cancer risk increased with increasing alcohol intake among women with BMI <25 kg/m2

[116]
10 Prospective
NHS
30–55 Self-report Cumulative average intake per day
  • ER+/PR+/AR+ (HR per drink/day = 1.11 [1.06–1.17]) (AR = androgen receptor)

  • ER−/PR−/AR− (HR per drink/day = 0.99 [0.88–1.12])

[117]
11 Prospective cohorts (2)
Danish
50+ Self-report Avg. drinks per week
  • Marked increase in breast cancer risk for hormone replacement therapy especially when combined with alcohol

  • This effect was primarily restricted to ER+ cases

[118]
2013 and previous
12 Case Control, 2013 Japanese cohort
1754 pre- and postmenopausal women
20–79 Self-reported alcohol drinking Avg. consumption g/day
  • 23 g/day (OR = 1.39 [95% CI: 1.07–1.80]) in postmenopausal women

  • ER−/PR−/HER2+ (OR = 2.99 [1.08–8.26])

  • ER−/PR−/HER2− (OR = 3.72 [1.30–10.67])

  • No significant positive association was observed among premenopausal women

  • Among postmenopausal women, no protective effect of folate was obvious across all subtypes, except ER−/PR−/HER2− (OR = 0.44 [0.20–0.96])

[119]
13 Prospective observational, 2011
Nurses’ Health Study 105,986 women
Avg. 60 Semiquantitative food frequency questionnaire Avg. daily consumption in g/day
  • At 5–9.9 g/day, or 0.5–1.0 drink:

    ER+/PR+ (RR = 1.14 [1.02–1.28])

    ER−/PR− (RR = 1.25 [1.01–1.54])

    ER+/PR− (RR = 1.07 [0.85–1.34])

    ER−/PR+ (RR = 1.47 [0.87–2.47])

  • Low levels of alcohol were associated with a small increase in breast cancer risk

[120]
14 Prospective control, 2011
Japanese cohort
19,227 patients
40–64 Food frequency questionnaire Avg. consumption g/day
  • ≥15 g/day, no significant relation to breast cancer risk

  • Moderate drinking does not increase breast cancer risk

[121]
15 Prospective, 2010 50,757 pre- and postmenopausal Japanese women 40–69 Self-reported questionnaires Average consumption g/week
  • >150 g/week RR = 1.78 (premenopausal), 1.21 (postmenopausal)

  • No effect of folate, body weight, flushing due to defective ALDH2

[122]
16 Case control, 2008
437 women
25–85 Structured questionnaire administered by two interviewers Average consumption g/day
  • <1.5 g/day decreases risk of breast cancer (OR = 0.58 [0.34–0.97])

  • Moderate drinking decreases risk of breast cancer

[123]